2-AA-Boc Glycan Labeling via Acid Deprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The use of anthranilic acid (2-AA) for glycan labeling is restricted due to its classification as a controlled substance, making it difficult to comply with DEA regulations, thereby limiting its availability for reductive amination in glycan analysis.
Innovation Solution
Conjugating anthranilic acid with a tert-butyloxycarbonyl (Boc) group (2-AA-Boc) and removing the Boc group using acids like trifluoroacetic acid or difluoroacetic acid at controlled temperatures and concentrations, allowing for the labeling of glycans while avoiding the regulatory issues associated with 2-AA itself.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If anthranilic acid (2-AA) is used for glycan labeling, then labeling sensitivity is improved, but regulatory compliance becomes difficult due to DEA restrictions
Solution Approach 1:
The compound 2-AA is segmented into two parts: a protected form (2-AA-Boc) that can be legally distributed and stored, and a reactive form (2-AA) that is generated in situ. The Boc protecting group is removed using acid treatment to release the active labeling agent only when needed, allowing compliance with DEA regulations while maintaining labeling sensitivity.
Solution Approach 2:
The Boc-protected form (2-AA-Boc) serves as an intermediary substance that bridges the gap between regulatory compliance and functional utility. This intermediate compound can be legally obtained and stored, then converted to the active 2-AA form through acid-catalyzed deprotection, enabling both compliance and sensitive labeling.
2Ease of operation
If Boc group is removed from 2-AA-Boc using acid treatment, then availability of active 2-AA is improved, but additional processing steps are required
Solution Approach 1:
The Boc protecting group is removed in advance through acid treatment to generate the active 2-AA form before the actual glycan labeling begins. This preliminary activation step simplifies the overall workflow by ensuring the labeling agent is ready in its active form, reducing complexity during the main labeling process.
Solution Approach 2:
The chemical state of the 2-AA compound is changed from protected (2-AA-Boc) to active (2-AA) by changing the pH parameter through acid treatment. This parameter change activates the labeling agent without requiring complex equipment or procedures, simply involving incubation with acid under controlled conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the use of 2-AA for glycan labeling while remaining compliant with DEA regulations, providing a sensitive and efficient labeling process that can be integrated into standard workflows with minimal modification.
Implementation Method 1
removing the Boc group by incubating the 2-AA-Boc with an acid for a time and at a temperature sufficient to remove the Boc group from the 2-AA-Boc
Implementation Method 2
incubating a solution containing the 2-AA and the glycan under conditions that allow the 2-AA to label the glycan
Data Source
AI summary
The present disclosure provides methods for using anthranilic acid (2-AA) blocked by tertbutyloxycarbonyl (Boc) groups in protocols for labeling glycans for analysis, and kits providing 2-AA-Boc and acids for unblocking blocked 2-AA for use in glycan labeling and analysis.